2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Sell
44
CACI Quote, Financials, Valuation and Earnings
Last price:
$428.01
Seasonality move
:
7.02%
Day range:
$417.16 - $433.14
52-week range:
$318.60 - $588.26
Dividend yield:
0%
P/E ratio:
20.20x
P/S ratio:
1.15x
P/B ratio:
2.54x
Volume:
476.5K
Avg. volume:
362.9K
1-year change:
1.1%
Market cap:
$9.4B
Revenue:
$7.7B
EPS (TTM):
$21.19
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $5.7B | $6B | $6.2B | $6.7B | $7.7B | |
| Revenue Growth (YoY) | 14.71% | 5.67% | 2.63% | 8.06% | 14.28% | |
| Cost of Revenues | $5.3B | $5.5B | $5.7B | $6.1B | $7B | |
| Gross Profit | $457.7M | $539.5M | $496.3M | $567.5M | $649.7M | |
| Gross Profit Margin | 8% | 8.93% | 8% | 8.47% | 8.48% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | $457.7M | $539.5M | $496.3M | $567.5M | $649.7M | |
| Net Interest Expenses | $56.1M | $39.8M | $41.8M | $83.9M | $105.1M | |
| EBT. Incl. Unusual Items | $401.6M | $499.6M | $454.6M | $483.6M | $544.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $80.2M | $42.2M | $87.8M | $98.9M | $124.7M | |
| Net Income to Company | $321.5M | $457.4M | $366.8M | $384.7M | $419.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $321.5M | $457.4M | $366.8M | $384.7M | $419.9M | |
| Basic EPS (Cont. Ops) | $12.84 | $18.52 | $15.64 | $16.59 | $18.76 | |
| Diluted EPS (Cont. Ops) | $12.61 | $18.30 | $15.49 | $16.43 | $18.60 | |
| Weighted Average Basic Share | $25M | $24.7M | $23.4M | $23.2M | $22.4M | |
| Weighted Average Diluted Share | $25.5M | $25M | $23.7M | $23.4M | $22.6M | |
| EBITDA | $568.4M | $664.8M | $631M | $709.1M | $791.9M | |
| EBIT | $457.7M | $539.5M | $496.3M | $567.5M | $649.7M | |
| Revenue (Reported) | $5.7B | $6B | $6.2B | $6.7B | $7.7B | |
| Operating Income (Reported) | $457.7M | $539.5M | $496.3M | $567.5M | $649.7M | |
| Operating Income (Adjusted) | $457.7M | $539.5M | $496.3M | $567.5M | $649.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6B | $1.6B | $1.7B | $1.9B | $2.2B | |
| Revenue Growth (YoY) | 5.89% | 2.07% | 10.12% | 11.08% | 11.85% | |
| Cost of Revenues | $1.4B | $1.5B | $1.6B | $1.8B | $2B | |
| Gross Profit | $151.4M | $125.4M | $155M | $181.3M | $196.4M | |
| Gross Profit Margin | 9.76% | 7.91% | 8.89% | 9.36% | 9.06% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | $151.4M | $125.4M | $155M | $181.3M | $196.4M | |
| Net Interest Expenses | $9M | $9.1M | $23.6M | $27.7M | $45.1M | |
| EBT. Incl. Unusual Items | $142.5M | $116.3M | $131.5M | $153.6M | $151.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $22.1M | $20.9M | $30.7M | $38.3M | $39.4M | |
| Net Income to Company | $120.3M | $95.4M | $100.7M | $115.4M | $111.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $120.3M | $95.4M | $100.7M | $115.4M | $111.9M | |
| Basic EPS (Cont. Ops) | $4.83 | $4.08 | $4.37 | $5.17 | $5.02 | |
| Diluted EPS (Cont. Ops) | $4.78 | $4.04 | $4.33 | $5.13 | $5.00 | |
| Weighted Average Basic Share | $24.9M | $23.4M | $23.1M | $22.3M | $22.3M | |
| Weighted Average Diluted Share | $25.2M | $23.6M | $23.3M | $22.5M | $22.4M | |
| EBITDA | $182.7M | $159.6M | $190.3M | $216.4M | $251.3M | |
| EBIT | $151.4M | $125.4M | $155M | $181.3M | $196.4M | |
| Revenue (Reported) | $1.6B | $1.6B | $1.7B | $1.9B | $2.2B | |
| Operating Income (Reported) | $151.4M | $125.4M | $155M | $181.3M | $196.4M | |
| Operating Income (Adjusted) | $151.4M | $125.4M | $155M | $181.3M | $196.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6B | $6.1B | $6.6B | $7.3B | $8.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $6.6B | $5.6B | $6.1B | $6.7B | $7.6B | |
| Gross Profit | -$602M | $488.5M | $538.5M | $600.8M | $755.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | $561.1M | $488.5M | $538.5M | $600.8M | $755.3M | |
| Net Interest Expenses | $38.5M | $42.3M | $71M | $104.9M | $137.5M | |
| EBT. Incl. Unusual Items | $522.6M | $446.2M | $467.6M | $495.8M | $617.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $108.4M | $35.4M | $97.6M | $102.8M | $141.2M | |
| Net Income to Company | $414.2M | $410.8M | $369.9M | $393M | $476.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $414.2M | $410.8M | $369.9M | $393M | $476.6M | |
| Basic EPS (Cont. Ops) | $16.52 | $17.50 | $15.86 | $17.46 | $21.35 | |
| Diluted EPS (Cont. Ops) | $16.31 | $17.31 | $15.70 | $17.31 | $21.19 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $683.5M | $619.8M | $680M | $742.4M | $930.3M | |
| EBIT | $561.1M | $488.5M | $538.5M | $600.8M | $755.3M | |
| Revenue (Reported) | $6B | $6.1B | $6.6B | $7.3B | $8.4B | |
| Operating Income (Reported) | $561.1M | $488.5M | $538.5M | $600.8M | $755.3M | |
| Operating Income (Adjusted) | $561.1M | $488.5M | $538.5M | $600.8M | $755.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.5B | $4.6B | $5B | $5.6B | $6.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $4.1B | $4.2B | $4.6B | $5.2B | $5.8B | |
| Gross Profit | $427.4M | $376.5M | $418.7M | $452M | $557.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | $427.4M | $376.5M | $418.7M | $452M | $557.5M | |
| Net Interest Expenses | $28M | $30.5M | $59.7M | $80.8M | $113.2M | |
| EBT. Incl. Unusual Items | $399.4M | $346M | $359M | $371.2M | $444.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $78.9M | $72.2M | $82M | $85.9M | $102.4M | |
| Net Income to Company | $320.5M | $273.8M | $277M | $285.3M | $342M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $320.5M | $273.8M | $277M | $285.3M | $342M | |
| Basic EPS (Cont. Ops) | $12.78 | $11.68 | $11.89 | $12.73 | $15.31 | |
| Diluted EPS (Cont. Ops) | $12.63 | $11.57 | $11.77 | $12.63 | $15.21 | |
| Weighted Average Basic Share | $75.3M | $70.4M | $70M | $67.2M | $67M | |
| Weighted Average Diluted Share | $76.1M | $71.1M | $70.6M | $67.8M | $67.5M | |
| EBITDA | $521M | $476M | $525M | $558.3M | $696.8M | |
| EBIT | $427.4M | $376.5M | $418.7M | $452M | $557.5M | |
| Revenue (Reported) | $4.5B | $4.6B | $5B | $5.6B | $6.3B | |
| Operating Income (Reported) | $427.4M | $376.5M | $418.7M | $452M | $557.5M | |
| Operating Income (Adjusted) | $427.4M | $376.5M | $418.7M | $452M | $557.5M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $107.2M | $88M | $114.8M | $115.8M | $134M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $779.3M | $763.9M | $800.6M | $763.5M | $885.6M | |
| Inventory | $65.2M | $79.7M | $99.4M | $130.6M | $118.4M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $72.3M | $283.6M | $69.3M | $68.7M | $90.8M | |
| Total Current Assets | $1.1B | $1.3B | $1.2B | $1.2B | $1.4B | |
| Property Plant And Equipment | $501.3M | $547.3M | $523M | $512.5M | $501.1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $3.4B | $3.6B | $4.1B | $4.1B | $4.2B | |
| Other Intangibles | $406.9M | $476.1M | $581.4M | $507.8M | $474.4M | |
| Other Long-Term Assets | $35.3M | $70M | $150.8M | $177.1M | $178.6M | |
| Total Assets | $5.5B | $6.2B | $6.6B | $6.6B | $6.8B | |
| Accounts Payable | $90M | $148.6M | $303.4M | $198.2M | $287.1M | |
| Accrued Expenses | $82.1M | $253.8M | $265.1M | $276.1M | $291.4M | |
| Current Portion Of Long-Term Debt | $46.9M | $46.9M | $30.6M | $45.9M | $61.3M | |
| Current Portion Of Capital Lease Obligations | $67.5M | $61.3M | $67.3M | $46.3M | $51.2M | |
| Other Current Liabilities | $29.8M | $17.6M | $37.4M | $44.4M | $38.8M | |
| Total Current Liabilities | $769.2M | $884.8M | $1B | $994M | $1.1B | |
| Long-Term Debt | $1.4B | $1.7B | $1.7B | $1.7B | $1.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.9B | $3.5B | $3.6B | $3.4B | $3.3B | |
| Common Stock | $4.3M | $4.3M | $4.3M | $4.3M | $4.3M | |
| Other Common Equity Adj | -$72.3M | -$36.3M | -$31.1M | -$5.1M | -$12.7M | |
| Common Equity | $2.7B | $2.7B | $3.1B | $3.2B | $3.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $135K | $135K | $135K | $135K | $135K | |
| Total Equity | $2.7B | $2.7B | $3.1B | $3.2B | $3.5B | |
| Total Liabilities and Equity | $5.5B | $6.2B | $6.6B | $6.6B | $6.8B | |
| Cash and Short Terms | $107.2M | $88M | $114.8M | $115.8M | $134M | |
| Total Debt | $1.4B | $1.7B | $1.7B | $1.7B | $1.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $105.6M | $125.1M | $106.8M | $159.2M | $223.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | $720M | $865.8M | $838.9M | $979.5M | |
| Inventory | $78.6M | $97.7M | $124.4M | $132.7M | $135.6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $83.8M | $113.3M | $72.7M | $87.9M | $107.3M | |
| Total Current Assets | $1.1B | $1.2B | $1.3B | $1.4B | $1.7B | |
| Property Plant And Equipment | $555.5M | $520.2M | $483.3M | $492.2M | $541.9M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $3.6B | $4.1B | $4.1B | $4.1B | $4.9B | |
| Other Intangibles | $493.1M | $601.5M | $524.4M | $490M | $1.1B | |
| Other Long-Term Assets | $48.8M | $80.4M | $159.8M | $178.7M | $165.7M | |
| Total Assets | $6B | $6.6B | $6.7B | $6.8B | $8.6B | |
| Accounts Payable | $109.7M | $218M | $323.3M | $363.5M | $305.1M | |
| Accrued Expenses | $304M | $301.3M | $358.8M | $402.7M | $415.7M | |
| Current Portion Of Long-Term Debt | $46.9M | $30.6M | $38.3M | $61.3M | $68.8M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $842.9M | $927.4M | $1.1B | $1.1B | $1.1B | |
| Long-Term Debt | $1.8B | $1.8B | $1.8B | $1.6B | $3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.5B | $3.6B | $3.6B | $3.4B | $4.9B | |
| Common Stock | $4.3M | $4.3M | $4.3M | $4.3M | $4.3M | |
| Other Common Equity Adj | -$39M | -$22.6M | -$23.4M | -$12.7M | -$23.4M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $135K | $135K | $135K | $135K | -- | |
| Total Equity | $2.5B | $3B | $3.1B | $3.4B | $3.7B | |
| Total Liabilities and Equity | $6B | $6.6B | $6.7B | $6.8B | $8.6B | |
| Cash and Short Terms | $105.6M | $125.1M | $106.8M | $159.2M | $223.9M | |
| Total Debt | $1.8B | $1.9B | $1.8B | $1.7B | $3.1B | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $321.5M | $457.4M | $366.8M | $384.7M | $419.9M | |
| Depreciation & Amoritzation | $110.7M | $125.4M | $134.7M | $141.6M | $142.1M | |
| Stock-Based Compensation | $29.3M | $30.5M | $31.7M | $39.6M | $53.9M | |
| Change in Accounts Receivable | $34.6M | -$38.2M | -$4.5M | $32.1M | -$127.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $518.7M | $592.2M | $745.6M | $388.1M | $497.3M | |
| Capital Expenditures | $72.3M | $73.1M | $74.6M | $63.7M | $63.7M | |
| Cash Acquisitions | -$106.2M | -$356.3M | -$615.5M | -$14.5M | -$90.2M | |
| Cash From Investing | -$178.5M | -$426.6M | -$689.1M | -$75.7M | -$152M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.7B | $3.3B | $2.5B | $3.2B | $3.1B | |
| Long-Term Debt Repaid | -$2B | -$3B | -$2.5B | -$3.3B | -$3.3B | |
| Repurchase of Common Stock | -$7.8M | -$509.1M | -$9.8M | -$273.2M | -$161.5M | |
| Other Financing Activities | -$40.1M | -$19.7M | -$21.2M | -$14.5M | -$20.8M | |
| Cash From Financing | -$303.4M | -$190.6M | -$21.2M | -$316.1M | -$326.9M | |
| Beginning Cash (CF) | $72M | $107.2M | $88M | $114.8M | $115.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $36.8M | -$25M | $35.2M | -$3.8M | $18.5M | |
| Ending Cash (CF) | $107.2M | $88M | $114.8M | $115.8M | $134M | |
| Levered Free Cash Flow | $446.4M | $519.1M | $671M | $324.3M | $433.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $120.3M | $95.4M | $100.7M | $115.4M | $111.9M | |
| Depreciation & Amoritzation | $31.2M | $34.2M | $35.2M | $35.1M | $55M | |
| Stock-Based Compensation | $8.8M | $8.4M | $10.4M | $12.1M | $12.8M | |
| Change in Accounts Receivable | -$113.1M | -$5.7M | -$135.6M | -$59M | -$38.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $118.2M | $284.2M | $28.9M | $198.3M | $230.3M | |
| Capital Expenditures | $19.4M | $17.1M | $15.2M | $11.7M | $16.2M | |
| Cash Acquisitions | -$325K | -$6.4M | -- | -$70.7M | -$72.7M | |
| Cash From Investing | -$17M | -$23.5M | -$13.5M | -$82.4M | -$88.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.3B | $352M | $1.3B | $889.5M | $1.5B | |
| Long-Term Debt Repaid | -$901.2M | -$609.2M | -$1B | -$972.3M | -$1.4B | |
| Repurchase of Common Stock | -$502.2M | -$2.3M | -$265.2M | -$2.7M | -$153.6M | |
| Other Financing Activities | -$918K | -$729K | -$846K | -$1.9M | -$1.3M | |
| Cash From Financing | -$97.7M | -$258M | -$26.3M | -$84.8M | -$98.8M | |
| Beginning Cash (CF) | $102.1M | $124.1M | $114.7M | $128.9M | $175.7M | |
| Foreign Exchange Rate Adjustment | -$90K | -$1.7M | $3.1M | -$676K | $5.6M | |
| Additions / Reductions | $3.6M | $2.7M | -$11M | $31.1M | $42.6M | |
| Ending Cash (CF) | $105.6M | $125.1M | $106.8M | $159.2M | $223.9M | |
| Levered Free Cash Flow | $98.8M | $267.1M | $13.7M | $186.6M | $214.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $414.2M | $410.8M | $369.9M | $393M | $476.6M | |
| Depreciation & Amoritzation | $122.4M | $131.2M | $141.5M | $141.7M | $175M | |
| Stock-Based Compensation | $30.9M | $29.7M | $39.2M | $44.1M | $63M | |
| Change in Accounts Receivable | -$20.7M | $47.6M | -$151.5M | $2.6M | -$108.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $661.4M | $684.7M | $388.5M | $492.2M | $548.2M | |
| Capital Expenditures | $69.2M | $60.6M | $76.7M | $64M | $60.2M | |
| Cash Acquisitions | -$359.2M | -$616.6M | $261K | -$96M | -$1.7B | |
| Cash From Investing | -$425.7M | -$676.3M | -$74.8M | -$157.2M | -$1.7B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.7B | $2.9B | $2.8B | $3.3B | $6.5B | |
| Long-Term Debt Repaid | -$2.4B | -$2.9B | -$2.9B | -$3.4B | -$5.1B | |
| Repurchase of Common Stock | -$508.9M | -$9.8M | -$272.9M | -$161.2M | -$167.1M | |
| Other Financing Activities | -$20.4M | -$21.1M | -$14.3M | -$20.3M | -$47.7M | |
| Cash From Financing | -$212.3M | $13.8M | -$329.9M | -$283.8M | $1.2B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $23.3M | $22.2M | -$16.2M | $51.2M | $62.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $592.2M | $624.1M | $311.8M | $428.3M | $488M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $320.5M | $273.8M | $277M | $285.3M | $342M | |
| Depreciation & Amoritzation | $93.6M | $99.5M | $106.3M | $106.4M | $139.3M | |
| Stock-Based Compensation | $23.8M | $23.1M | $30.6M | $35M | $44.1M | |
| Change in Accounts Receivable | -$18.8M | $67M | -$80.1M | -$109.6M | -$90.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $500.5M | $593M | $236M | $340.1M | $391M | |
| Capital Expenditures | $51.3M | $38.7M | $40.8M | $41.1M | $37.6M | |
| Cash Acquisitions | -$355.5M | -$615.8M | -- | -$81.6M | -$1.6B | |
| Cash From Investing | -$404M | -$653.6M | -$39.2M | -$120.7M | -$1.7B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2.5B | $2.1B | $2.4B | $2.4B | $5.8B | |
| Long-Term Debt Repaid | -$2.1B | -$2B | -$2.3B | -$2.4B | -$4.3B | |
| Repurchase of Common Stock | -$506.6M | -$7.3M | -$270.4M | -$158.4M | -$164M | |
| Other Financing Activities | -$19.6M | -$21M | -$14.1M | -$19.9M | -$46.9M | |
| Cash From Financing | -$103.5M | $100.8M | -$207.9M | -$175.6M | $1.4B | |
| Beginning Cash (CF) | $334.2M | $316.6M | $366.2M | $370.2M | $750.4M | |
| Foreign Exchange Rate Adjustment | $5.4M | -$3.2M | $3.1M | -$357K | $1.7M | |
| Additions / Reductions | -$7M | $40.3M | -$11.2M | $43.8M | $88.2M | |
| Ending Cash (CF) | $332.6M | $353.6M | $358.2M | $413.6M | $840.3M | |
| Levered Free Cash Flow | $449.2M | $554.3M | $195.1M | $299M | $353.4M | |
Get CACI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CACI
Sector
P/E ratio
20.20x
17.64x
PEG ratio
0.90x
0.25x
P/B ratio
2.54x
1.70x
Price / LTM sales
1.15x
0.92x
Growth Metrics
CACI
Sector
Revenue growth
11.85%
2.12%
Earnings growth
-2.53%
3.46%
Revenue (5-year growth)
8.97%
4.41%
Earnings forecast
$5.60
$0.29
Profitability
CACI
Sector
Profitability FY 2024
$649.7M
$401.8M
Return on invested capital
8.16%
5.41%
Return on assets
6.29%
3.55%
Return on equity
13.26%
8.69%
Earnings Date
Last Earnings Date
Apr
24
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Jul
24
Balance Sheet
CACI
Sector
Total cash
$223.9M
$162.1M
Short term investments
--
$38.3M
Total assets
$6.8B
$1.8B
Long term debt
$3.1B
$276M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Where Will Dell Stock Be in 5 Years?
So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
